Unconfigured Ad

Collapse
X
 
  • Time
  • Show
Clear All
new posts
  • lexogen
    Registered Vendor
    • Aug 2012
    • 49

    #1

    Call for Early Access Program of Mix-Square algorithm for RNA-Seq analysis

    Mix-Square is a software tool for the accurate quantification of transcript isoforms for RNA-Seq data generated from NGS

    Lexogen is seeking participants for an early access program for this novel algorithm

    Mix-Square, a new algorithm for accurate RNA-seq data analysis

    Fragment bias in RNA-Seq poses a serious challenge to the accurate quantification of gene isoforms. The novel Mix-Square algorithm makes no assumptions about fragment bias but fits a mixture model to the data, thus inferring the bias automatically. This yields more accurate abundance estimates and can further be used to investigate the types of positional bias present in RNA-Seq data. On publicly available RNA-Seq test sets Lexogen showed that the Mix-Square model leads to considerably better correlation between known and estimated isoform concentration than Cufflinks and PennSeq. This, in turn, results in substantially increased accuracy in the detection of differential expression (further details can be found in the manuscript http://biorxiv.org/content/early/2014/11/24/011767).

    Application

    Lexogen is looking for applicants for this program. Applications should be completed by January 18th through the following web page: http://goo.gl/forms/sQoJtVeqeX

    Participation

    Lexogen will review the applications, and select 50 participants. These participants will be given a stand-alone executable of the Mix-Square software for free use on their own RNA-Seq data.

    Reports and Prizes

    We ask participants to submit reports in free format including results generated with the Mix-Square software. The emphasis of these reports should be on the comparison with their previous algorithms. The most comprehensive reports will be rewarded with the following prizes.

    Prizes

    1st place : MacBook Air 11 inch, Intel Core i5, 128Gb, one person
    2nd and 3rd places : iPad Mini 2 Retina, 16Gb Wifi
  • dpryan
    Devon Ryan
    • Jul 2011
    • 3478

    #2
    You might consider posting this over at biostars.org as well if you haven't already done so.

    Comment

    • lexogen
      Registered Vendor
      • Aug 2012
      • 49

      #3
      The announcement is on Biostars as well. Thanks!

      Comment

      Latest Articles

      Collapse

      • SEQadmin2
        Beyond CRISPR/Cas9: Understand, Choose, and Use the Right Genome Editing Tool
        by SEQadmin2



        CRISPR/Cas9 sparked the gene editing revolution for both research and therapeutics.1 But this system still showed severe issues that limited its applications. The most prominent were the heavy reliance on PAM sequences, delivery limitations, double-stranded breaks that prompt unintended edits and cell death, and editing inefficiency (both in targeting and in knock-in reliability).

        Despite this, “CRISPR helped turn genome editing from a specialized technique into
        ...
        07-31-2026, 11:01 AM
      • SEQadmin2
        Proteomic Platforms: How to Choose the Right Analytical Strategy to Improve Detection and Clinical Applications
        by SEQadmin2


        Proteomics platforms are evolving rapidly, with advances in mass spectrometry and affinity-based approaches expanding what researchers can detect and at what scale. As the field moves toward deeper proteome coverage and clinical applications, scientists face an increasingly complex landscape of tools. This article will explore how researchers are navigating these choices to find the right platform for their work.

        The systematic characterization of the human proteome has
        ...
        07-20-2026, 11:48 AM
      • SEQadmin2
        Advanced Sequencing Platforms Tackle Neuroscience’s Toughest Genomics Problems
        by SEQadmin2



        Genomics studies in neuroscience face a special challenge due to the brain’s complexity and scarcity of samples. Mapping changes in cell type and state using conventional next-generation sequencing methods remains challenging. Advances in technologies like single-cell sequencing, spatial transcriptomics, and long-read sequencing have opened the door to deeper studies of the brain and diseases like Alzheimer’s, amyotrophic lateral sclerosis (ALS), and schizophrenia.
        ...
        07-09-2026, 11:10 AM

      ad_right_rmr

      Collapse

      News

      Collapse

      Topics Statistics Last Post
      Started by SEQadmin2, 08-03-2026, 10:13 AM
      0 responses
      15 views
      0 reactions
      Last Post SEQadmin2  
      Started by SEQadmin2, 07-31-2026, 02:55 AM
      0 responses
      32 views
      0 reactions
      Last Post SEQadmin2  
      Started by SEQadmin2, 07-24-2026, 12:17 PM
      0 responses
      23 views
      0 reactions
      Last Post SEQadmin2  
      Started by SEQadmin2, 07-23-2026, 11:41 AM
      0 responses
      21 views
      0 reactions
      Last Post SEQadmin2  
      Working...